Monitoring Autophagy and Resveratrol's Impact on Breast Cancer Cells
Author Information
Author(s): Liao Chiao-Chun, Long Yuqing, Tsai Ming-Lin, Lin Chun-Yu, Hsu Kai-Wen, Lee Chia-Hwa
Primary Institution: National Yang Ming Chiao Tung University
Hypothesis
The study aims to develop a non-invasive autophagy detection system to assess the synergistic effects of resveratrol and doxorubicin on breast cancer cells.
Conclusion
The G-cleave LC3B biosensor effectively monitors autophagy and shows that resveratrol enhances the apoptotic effects of doxorubicin in breast cancer cells.
Supporting Evidence
- The G-cleave LC3B biosensor showed strong concordance with established autophagy metrics.
- Resveratrol significantly potentiated apoptosis in MDA-MB-231 cells when combined with doxorubicin treatment.
- The biosensor allows for rapid and reliable assessment of autophagy activity.
- Autophagy plays a dual role in cancer, acting as both a tumor suppressor and promoter.
Takeaway
This study created a new tool to see how cells recycle themselves, and it found that a natural compound from grapes can help cancer treatments work better.
Methodology
The study developed a G-cleave LC3B biosensor to monitor autophagy in breast cancer cells and tested the effects of resveratrol and doxorubicin on apoptosis.
Limitations
The study primarily focuses on in vitro models, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website